Sovesudil
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Mar 6, 2017 (NCT03106532)
Timeline
Indications
Mechanism of action
- Rho-associated protein kinase 1INHIBITOR
ROCK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- php-201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04863365 | Phase 3 | Nov 30, 2021 | pH Pharma |
| NCT03586908 | Phase 1 | Feb 4, 2018 | pH Pharma |
| NCT03106532 | Phase 2 | Mar 6, 2017 | pH Pharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| pH Pharma | For profit | 3 | 3 | 3 | 2017 |
1 organizations
Page 1 / 1